
Senior Lecturer @blizard_inst. I am an immunologist. My lab works on life-course immunology with a focus on barrier immunity. she/her
London
Joined January 2015
- Tweets776
- Following1K
- Followers1.4K
- Likes1.8K
Pinned Tweet
I am so excited to start my new @Barts_Charity funded project investigating how menopause and HRT impacts upon immunity. But we are in need of volunteers to help with the study :)
This is my new paper on menopause ageing monocytes and how HRT can prevent immune ageing :) So happy that is out :) qmul.ac.uk/media/news/2025/m…
Hormone replacement therapy helps restore immune function in menopausal women, reducing inflammaging and preserving monocyte function. open-access
onlinelibrary.wiley.com/doi/…
Extends what I previously summarized from immune system clocks erictopol.substack.com/p/new…
Dr Emma S Chambers retweeted
🚨The Menon lab is hiring a Postdoc!
Interested in mucosal immunology? Come join our team to study lung-infiltrating B cell dynamics in COPD & other chronic lung diseases @UKRI_News @LydiaBeckerIII
🗓️Apply by Jan 29th
Please help spread the word!
jobs.manchester.ac.uk/Job/Jo…
Dr Emma S Chambers retweeted
***Fully funded PhD position*** @blizard_inst with myself and @Giovannoni62497 to investigate CD40 signalling in Epstein Barr Virus-infected B-cells in people with multiple sclerosis. Please spread the word! findaphd.com/phds/project/cd…
This week I am at the @BTSrespiratory Winter Meeting #BTSWinter2024. I am looking forward to discussing my new work on the influence of old age on asthma immunephenotype tomorrow morning at 8.50am in the discovery science session.
Dr Emma S Chambers retweeted
We're pleased to share our new preprint on modelling dynamic immune responses in human skin! It has been a tremendous effort from everyone involved and we're excited to continue this new direction of research in immuno-competent skin models. biorxiv.org/content/10.1101/…
Dr Emma S Chambers retweeted
Our newest paper is out! 🚨 We have uncovered multiple cellular senescence-associated defects in melanocytes and other cell types in Familial Melanoma Syndrome (FMS) patients with a p16 defect that makes them more susceptible to developing melanoma ⬇️
onlinelibrary.wiley.com/doi/…
Dr Emma S Chambers retweeted
The newest researcher investigated the biology of skin cells taken from people who don’t produce the senescence-related compound p16.
lifespan.io/news/the-reason-…
by Josh Conway
@ucl @Emma_S_Chambers #aging #cancer #SASP #FMS
If you are between 40-60 years and are happy to come to Whitechapel for a one off blood donation, please do get in contact to received more information
Just back from annual leave to see that I have been promoted to Senior Lecturer :) @blizard_inst
We just had a lovely lab outing to the sky garden in London. I really appreciate all the hard work my lab members have put in over the past year :)
Dr Emma S Chambers retweeted
Diabetes UK's Havering Volunteer Support Group's next meeting features Dr Emma Chambers giving a talk on “Ageing and Immunity.”
📅 Monday, 17 June 2024
📍 Large Hall, 24 North Street, Hornchurch RM11 1QX
🕗 8pm
🎫 £2, which incl. tea and coffee
For more info call: 01708 935779
Dr Emma S Chambers retweeted
⏰ Our #EarlyCareer Development #Grant applications close this week!
We are offering these grants to #ECR CARINA members to boost their #ProfessionalDevelopment & help them reach their #CareerGoals 🤩
Apply by 23:59 BST this Wed 12 June 👉bit.ly/3xZO3nL
This is such an important article and something I feel passionately needs to improve.
As #UKRIFLFs navigating travel w/ caring responsibilities myself @DrLauraWolz & @CarterL_J are calling for accelerated change - sharing insights into challenges faced highlighting personal experiences & proposing a strategy for institutions @NatureCareers nature.com/articles/d41586-0…
I am delighted to say that our new paper investigating the impact of an individual's characteristics on covid-19 vaccine immunogenicity is now published @npjvaccines
doi.org/10.1038/s41541-024-0… @blizard_inst (1/6).
In keeping with previous work in the field, we observed that age was an important factor for vaccine immunogenicity. Increasing age was independently associated with lower anti-S antibody titres post-vaccination. No difference in cellular antigen specific immunity was (5/6)











